Mannatech (NASDAQ:MTEX) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Mannatech (NASDAQ:MTEX) to a buy rating in a research note issued to investors on Saturday morning,Wall Street Zen reports.

Separately, Weiss Ratings raised Mannatech from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Thursday, October 29th. One investment analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, the stock currently has an average rating of “Sell”.

Mannatech Stock Performance

Mannatech stock opened at $8.95 on Friday. The company’s fifty day simple moving average is $7.92 and its 200-day simple moving average is $6.34. Mannatech has a 12 month low of $3.80 and a 12 month high of $9.97.

Mannatech (NASDAQ:MTEX) last announced its quarterly earnings data on Wednesday, August 12th. The company reported $0.53 earnings per share (EPS) for the quarter. The business had revenue of $26.65 million during the quarter. Mannatech had a negative return on equity of 2,383.34% and a negative net margin of 6.90%.

Mannatech Company Profile

Mannatech, Incorporated develops and markets nutritional supplements, health and wellness products, and personal-care products through a direct-selling business model. Its product offerings have included dietary supplements, functional nutrition products, weight-management formulas, and skin-care products, with an emphasis on ingredients intended to support general wellness and healthy aging.

The company is best known for its Ambrotose product line, which incorporates plant-sourced polysaccharides, as well as related nutritional supplements and wellness programs.